Last reviewed · How we verify
Irinotecan Hydrochloride Injection（CAMPTO®）
Irinotecan Hydrochloride Injection（CAMPTO®） is a Small molecule drug developed by Luye Pharma Group Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | Irinotecan Hydrochloride Injection（CAMPTO®） |
|---|---|
| Sponsor | Luye Pharma Group Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment (PHASE3)
- 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma (PHASE2)
- Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) (PHASE1)
- A Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas (PHASE1)
- Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer (PHASE3)
- Resection Observatory
- Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients (PHASE2)
- Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Irinotecan Hydrochloride Injection（CAMPTO®） CI brief — competitive landscape report
- Irinotecan Hydrochloride Injection（CAMPTO®） updates RSS · CI watch RSS
- Luye Pharma Group Ltd. portfolio CI
Frequently asked questions about Irinotecan Hydrochloride Injection（CAMPTO®）
What is Irinotecan Hydrochloride Injection（CAMPTO®）?
Irinotecan Hydrochloride Injection（CAMPTO®） is a Small molecule drug developed by Luye Pharma Group Ltd..
Who makes Irinotecan Hydrochloride Injection（CAMPTO®）?
Irinotecan Hydrochloride Injection（CAMPTO®） is developed by Luye Pharma Group Ltd. (see full Luye Pharma Group Ltd. pipeline at /company/luye-pharma-group-ltd).
What development phase is Irinotecan Hydrochloride Injection（CAMPTO®） in?
Irinotecan Hydrochloride Injection（CAMPTO®） is in Phase 1.